2011年度このページを印刷する - 2011年度

  1. Tachibana K, Inoue Y, Nishiyama A et al. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: Serum IL-7 as a prognostic marker. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28: 113-22.
  2. Asami K, Kawahara M, Atagi S et al. Duration of prior gefitinib treatment predicts survival potential in patients with lung adenocarcinoma receiving subsequent erlotinib. Lung Cancer  2011; 73: 211-6.
  3. Funakoshi Y, Sawabata N, Takeuchi Y et al. Clinical implication of pulmonary excision for undiagnosed peripheral lung cancer. Interact Cardiovasc Thorac Surg 2011; 13: 485-9.
  4. 倉原 優, 橘 和延, 桂 浩ら. 局所麻酔下胸腔鏡による掻爬とドレナージが有用であったクリプトコッカス膿胸の1例. 日呼吸会誌, 49:142-147,
  5. 竹崎 彰夫, 新井 徹, 井上 義一ら.Pulmonary tumor thrombotic microangiopathyによる急性呼吸不全を呈し,血清vascular endothelial growth factor-Dの上昇を認めた胃癌の1剖検例. 日呼吸会誌, 2011:49: 890-896,
  6. 杉本 親寿, 新井 徹, 西山 明秀ら. 全肺洗浄を施行した自己免疫性肺胞蛋白症8例の手技,効果,安全性の多面的評価秀. 日呼吸会誌, 2011: 569-576,
  7. Hayashi S, Oji Y, Kanai Y,et al. Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer. Cancer Invest. 2011;30:165-71.
  8. Asami K, Koizumi T, Hirai K,et al. Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study. Clin Lung Cancer. 2011,12:387-92.
  9. Akira M, Inoue Y, Arai T, et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax. 2011,66:61-5.
  10. Okada M, Kita Y, Kanamaru N, et al. Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice. Clin Dev Immunol. 2011;2011:404929.
  11. Okada M, Kita Y, Nakajima T,et al. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis. Hum Vaccin. 2011 Jan-Feb;7 Suppl:60-7.
  12. Okada M, Kita Y, Nakajima T, et al. Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis. Clin Dev Immunol. 2011;2011:549281.
  13. Kita Y, Okada M, Nakajima T, et al. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models. Hum Vaccin. 2011 Jan-Feb;7 Suppl:108-14.
  14. Kubo A, Koh Y, Kawaguchi T, et al. Malignant pleural effusion from lung adenocarcinoma treated by gefitinib. Intern Med. 2011;50:745-8.